Glucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimising systemic activity (vol 6, pg 137, 2013)

被引：0
|
作者：
Prantera, C. [1 ]
Marconi, Stefano [1 ]
机构：
[1] Chiesi Farmaceutici SpA, Parma, Italy
来源：
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY | 2013年 / 6卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：420 / 420
页数：1
相关论文
共 50 条
  • [41] Fluoride: a risk factor for inflammatory bowel disease? (vol 51, pg 1019, 2016)
    Follin-Arbelet, B.
    Moum, B.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (11)
  • [42] Perioperative Dietary Therapy in Inflammatory Bowel Disease (vol 14, pg 431, 2020)
    不详
    JOURNAL OF CROHNS & COLITIS, 2023, 17 (01): : 149 - 149
  • [43] Is there a role for therapeutic sphingolipids in inflammatory bowel disease? (vol 12, pg 876, 2020)
    Parigi, T. L.
    Roda, G.
    Argollo, M.
    Gilardi, D.
    Danese, S.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (03) : I - I
  • [44] Biologic therapy of inflammatory bowel disease. (vol 122, pg 1592, 2002)
    Sandborn, WJ
    Targan, SR
    GASTROENTEROLOGY, 2002, 123 (02) : 656 - 656
  • [45] Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease (vol 81, pg 333, 2021)
    Hanzel, Jurij
    Ma, Christopher
    Vande Casteele, Niels
    Khanna, Reena
    Jairath, Vipul
    Feagan, Brian G.
    DRUGS, 2021, 81 (14) : 1697 - 1697
  • [46] New and Emerging Treatments for Inflammatory Bowel Disease (vol 104, pg 74, 2023)
    Higashiyama
    Hokari, Ryota
    DIGESTION, 2023,
  • [47] An Integrated Taxonomy for Monogenic Inflammatory Bowel Disease (vol 162, pg 859, 2022)
    Bolton, Chrissy
    Smillie, Christopher S.
    Pandey, Sumeet
    Elmentaite, Rasa
    Wei, Gabrielle
    Argmann, Carmen
    Aschenbrenner, Dominik
    James, Kylie R.
    McGovern, Dermot P. B.
    Macchi, Marina
    Cho, Judy
    Shouval, Dror S.
    Kammermeier, Jochen
    Koletzko, Sibylle
    Bagalopal, Krithika
    Capitani, Melania
    Cavounidis, Athena
    Pires, Elisabete
    Weidinger, Carl
    McCullagh, James
    Arkwright, Peter D.
    Haller, Wolfram
    Siegmund, Britta
    Peters, Lauren
    Jostins, Luke
    Travis, Simon P. L.
    Anderson, Carl A.
    Snapper, Scott
    Klein, Christoph
    Schadt, Eric
    Zilbauer, Matthias
    Xavier, Ramnik
    Teichmann, Sarah
    Muise, Aleixo M.
    Regev, Aviv
    Uhlig, Holm H.
    GASTROENTEROLOGY, 2022, 162 (07) : 2143 - 2143
  • [48] MicroRNAs: new players in inflammatory bowel disease (vol 64, pg 504, 2015)
    Kalla, R.
    Ventham, N. T.
    Kennedy, N. A.
    GUT, 2015, 64 (06) : 1008 - 1008
  • [49] Evaluation of new therapies for inflammatory bowel disease (vol 56, pg 351, 2003)
    Carty, E
    Rampton, DS
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (05) : 584 - 584
  • [50] 6-MERCAPTOPURINE (6-MP) IN THE TREATMENT OF INFLAMMATORY DISEASE OF THE BOWEL (IDB)
    BARREIRO, MA
    GASTROENTEROLOGY, 1987, 92 (05) : 1308 - 1308
12345